Ipswich Investment Management Co. Inc. Has $254,000 Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Ipswich Investment Management Co. Inc. decreased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,255 shares of the company’s stock after selling 153 shares during the quarter. Ipswich Investment Management Co. Inc.’s holdings in GE HealthCare Technologies were worth $254,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Blue Trust Inc. grew its position in GE HealthCare Technologies by 9.9% in the 3rd quarter. Blue Trust Inc. now owns 2,334 shares of the company’s stock valued at $219,000 after purchasing an additional 210 shares during the period. Allspring Global Investments Holdings LLC grew its position in GE HealthCare Technologies by 2.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company’s stock valued at $2,317,000 after purchasing an additional 562 shares during the period. Sequoia Financial Advisors LLC grew its position in GE HealthCare Technologies by 42.5% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 13,217 shares of the company’s stock valued at $1,240,000 after purchasing an additional 3,941 shares during the period. Signaturefd LLC grew its position in GE HealthCare Technologies by 4.0% in the 3rd quarter. Signaturefd LLC now owns 4,524 shares of the company’s stock valued at $425,000 after purchasing an additional 174 shares during the period. Finally, Eastern Bank acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at $204,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the subject of several research reports. Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. One analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Trading Down 1.1 %

NASDAQ GEHC opened at $91.09 on Friday. The stock has a market capitalization of $41.66 billion, a price-to-earnings ratio of 21.04, a PEG ratio of 3.20 and a beta of 1.15. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The business’s fifty day moving average is $85.05 and its 200-day moving average is $85.83.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.